I found it quite well-written. Why so?
322 karma · joined December 13, 2019
If you have any further reading on this please share.
n=1 with exception for scientific papers I do essentially all my reading on my phone and I do not experience any attention difference. I also have my phone on perpetual DnD so notifications and other distractions are not a thing.
I don’t know what your seniority is and what you’ve seen but I can assure you it exists, and it’s not unique exceptions. Maybe a good opportunity to interview if you’re feels it’s unattainable where you are now. Plenty of US companies hiring remotely too…
Swedish tax rates on income makes this two to three times as difficult (approaches 60% plus 30% social paid by the employer this includes RSUs as well, plus 25% VAT) but it’s nonsense to claim this doesn’t happen. I am Swedish and have made significantly more in tech than the author. So has many of my friends.
With that said, the only reason I’m still in Sweden is family. The public sentiment about the future is uncomfortably racist and increasingly hostile about fortune making. If you have the mobility my advice is to move. Good luck.
First it's iPhone photos, then it's all iCloud files, that spills into Macs using iCloud, then it's client side reporting of local Mac files, and somewhere along all other Apple hardware I've filled my home with have received equivalent updates and are phoning home to verify that I don't have files or whatever data they can see or hear that some unknown authority has decided should be reported.
What is the utopian perspective of this which counterbalances the risks for this to be a path worth taking?
For medicinal products I’d be keen to see research on whether a treatment group being re-targeted would report better efficiency of a treatment than a non-retargeted control.
Apple charges commission for your paid application regardless of distribution form because there is only one and you have to use it, the AppStore. Shopify has an optional distribution platform for apps which they charge a fee for. You can distribute your app on your own and avoid the fee.
Just 20 years ago the first disease modification treatments were introduced. These were recurring injections of interferon-beta (1b/1a) for a 18-38% reduction in relapses and annual relapse rate (ARR) of 0.256[1]. Today there are about 20 different options, with Rituximab and humanized variants indicating an annual relapse rate of 0.044 for RRMS patients with a well understood safety profile[2]. On such medications an MS patient can expect a relapse every 22 years vs every 2.5 years unmedicated.
My pet theory is that MS research will ultimately lead to significant breakthroughs in longevity research. This is based on the morbid view that the disease is serious enough for risks to be taken in understanding auto-immune responses, crossing the blood brain barrier and remyelination.
https://d2r55xnwy6nx47.cloudfront.net/uploads/2020/07/Plants...
I’d rather say Linux gives you choices. Choices that you have to make, rather than options with (sensible) defaults. This is a big reason for why I’ve been unable to switch from macos to Linux as a daily driver every time I’ve tried in the past ten years.
Ironically, it’s simply too costly. Macos has been degrading over the past 6-7 years, but it’s still pretty good at standing out the way.
I’m gladly proven wrong if you can point at a path I’ve missed.
Separately Sweden is also a country with an extensive social safety net, where every citizen has the right to free healthcare and every employee will receive 80% of their salary for two weeks without a doctor's note at no cost for the employer[2].
Time will tell if the Swedish approach was the right one and even if so the Swedish case will end up being dependant on rather unique constraints that simply will not map to the US, at least not on a national level.
[1] https://en.wikipedia.org/wiki/Second_Amendment_to_the_United... [2] https://ec.europa.eu/social/main.jsp?catId=1130&langId=en&in...
It's a relevant perspective, but I can't seem to find any source for IMF claiming that. Do you have one or are you referring to research publicized by Oxfam[1]?
[1] https://www.businessinsider.com/google-employee-tests-positi...
In the topic of restricting access to others the author says:
But I ask myself: How difficult can it be for a billion dollar revenue company?
Pretty difficult when the law prohibits you[1]. Hopefully that forces regulation to cover the weaponization of technology not access to data. Right now this comes off as; you’re not allowed to enrich uranium, unless you own the land.
[1] https://www.eff.org/deeplinks/2019/09/victory-ruling-hiq-v-l...
Facebook's incentives with React Native are somewhat unclear. This is a big, yet often unspoken, reason companies are vary of depending on React Native for their mobile stacks. With more large companies such as Microsoft, and now Shopify getting behind React Native those incentives will have to please a larger group and should become much more aligned with mobile developer communities at large - and not just Facebook's desires.
If Shopify manages to play an active role in the development of React Native and expand the project beyond the sole control of Facebook then React Native will become a much more viable option for companies who for political reasons have refrained from using the technology.
We don’t yet know how dangerous the new coronavirus is – and we won’t know until more data comes in. Twenty-six deaths out of 800 reported cases would mean a 3% mortality rate. However, this is likely to be a overestimate since there may be a far larger pool of people who have been infected by the virus but who have not suffered severe enough symptoms to attend hospital and so have not been counted in the data. For comparison, seasonal flu typically has a mortality rate below 1% and is thought to cause about 400,000 deaths each year globally. Another key unknown, of which scientists should get a clearer idea in the coming weeks, is how contagious the coronavirus is. A crucial difference is that unlike flu, there is no vaccine for the new coronavirus, which means it is more difficult for vulnerable members of the population – elderly people or those with existing respiratory or immune problems – to protect themselves. One sensible step to get the flu vaccine, which will reduce the burden on health services if the outbreak turns into a wider epidemic.
https://www.theguardian.com/science/2020/jan/24/what-is-the-...